Kwality Pharma is in the business of manufacturing & trading in Pharmaceuticals & allied productsBusiness Overview: KPL is in an ANVISA and EU GMP certified manufacturer of all pharma products including complex molecules across all dosage forms including niche Biologics. It has a portfolio of 3000+ formulations across 25+ therapeutic...
Proceedings of 43rd Annual General Meeting attached herewith.
Kwality Pharmaceutical has raised its FY27 guidance, with revenue now projected at over 700 Cr, EBITDA between 189-196+ Cr, and PAT exceeding 109 Cr, driven by strong execution and market visibility. The financial results for the quarter saw revenue of 162.4 Cr, EBITDA of 41 Cr, and a profit after...
Kwality Pharma (KPL) reports strong Q1 FY27. Revenue rose 46% YoY to ₹162 Cr, and PAT surged 119% to ₹26 Cr. Management upgraded FY27 guidance: Revenue ₹700+ Cr, PAT ₹109+ Cr. R&D is advancing with 13 BE studies completed and new product registrations.
